Intermittent Preventive Therapy with Sulfadoxine-Pyrimethamine for Malaria in Pregnancy: A Cross-Sectional Study from Tororo, Uganda

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Arinaitwe, Emmanuel ^a   Ades, Veronica ^b   Walakira, Andrew ^a   Ninsiima, Boaz ^a   Mugagga, Olive ^a   Patil, Teja S ^b   Schwartz, Alanna ^b   Kamya, Moses R ^c   Nasr, Sussann ^d   Chang, Michelle ^d   Filler, Scott ^e   Dorsey, Grant ^b  

^a INFECTIOUS DISEASES RESEARCH COLLABORATION   (Uganda)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c MAKERERE UNIVERSITY COLLEGE OF HEALTH SCIENCES   (Uganda)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^e The Global Fund to Fight Acquired Immune Deficiency Syndrome Tuberculosis and Malaria   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

PYRIMETHAMINE PLUS SULFADOXINE;

ADULT; ADVERSE OUTCOME; ANEMIA; ARTICLE; BLOOD SMEAR; CROSS-SECTIONAL STUDY; DRUG EFFICACY; DRUG INTERMITTENT THERAPY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFECTION PREVENTION; INTERMITTENT PREVENTIVE THERAPY; LOW BIRTH WEIGHT; MALARIA; PARASITEMIA; PLACENTA MALARIA; POLYMERASE CHAIN REACTION; PREGNANCY OUTCOME; PREGNANT WOMAN; PREVALENCE; UGANDA;

ADULT; CROSS-SECTIONAL STUDIES; DIHYDROPTEROATE SYNTHASE; DOCUMENTATION; DRUG COMBINATIONS; DRUG RESISTANCE; FEMALE; HUMANS; MALARIA; MUTATION; PARTURITION; PREGNANCY; PREGNANCY COMPLICATIONS; PYRIMETHAMINE; SULFADOXINE; TETRAHYDROFOLATE DEHYDROGENASE; UGANDA; YOUNG ADULT;

EID: 84883412694     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0073073     Document Type: Article

References (30)

1. Desai M, ter Kuile FO, Nosten F, McGready R, Asamoa K, et al. (2007) Epidemiology and burden of malaria in pregnancy. Lancet Infect Dis 7: 93-104.
2. Parise ME, Ayisi JG, Nahlen BL, Schultz LJ, Roberts JM, et al. (1998) Efficacy of sulfadoxine-pyrimethamine for prevention of placental malaria in an area of Kenya with a high prevalence of malaria and human immunodeficiency virus infection. Am J Trop Med Hyg 59: 813-822.
3. Schultz LJ, Steketee RW, Macheso A, Kazembe P, Chitsulo L, et al. (1994) The efficacy of antimalarial regimens containing sulfadoxine-pyrimethamine and/or chloroquine in preventing peripheral and placental Plasmodium falciparum infection among pregnant women in Malawi. Am J Trop Med Hyg 51: 515-522.
4. Shulman CE, Dorman EK, Cutts F, Kawuondo K, Bulmer JN, et al. (1999) Intermittent sulphadoxine-pyrimethamine to prevent severe anaemia secondary to malaria in pregnancy: a randomised placebo-controlled trial. Lancet 353: 632-636.
5. Verhoeff FH, Brabin BJ, Chimsuku L, Kazembe P, Russell WB, et al. (1998) An evaluation of the effects of intermittent sulfadoxine-pyrimethamine treatment in pregnancy on parasite clearance and risk of low birthweight in rural Malawi. Ann Trop Med Parasitol 92: 141-150.
6. World Health Organization; Global Malaria Program. (2012) Updated WHO Policy Recommendation (October 2012): Intermittent Preventative Treatment of Malaria in Pregnancy Using Sulfadoxine-Pyrimethamine (IPTp-SP). Geneva, Switzerland: World Health Organization.
7. Sandison TG, Homsy J, Arinaitwe E, Wanzira H, Kakuru A, et al. (2011) Protective efficacy of co-trimoxazole prophylaxis against malaria in HIV exposed children in rural Uganda: a randomised clinical trial. BMJ 342: d1617.
8. Taylor SM, Antonia AL, Chaluluka E, Mwapasa V, Feng G, et al. (2012) Antenatal receipt of sulfadoxine-pyrimethamine does not exacerbate pregnancy-associated malaria despite the expansion of drug-resistant Plasmodium falciparum: clinical outcomes from the QuEERPAM study. Clin Infec Dis 55: 42-50.
9. Gosling RD, Gesase S, Mosha JF, Carneiro I, Hashim R, et al. (2009) Protective efficacy and safety of three antimalarial regimens for intermittent preventive treatment for malaria in infants: a randomised, double-blind, placebo-controlled trial. Lancet 374: 1521-1532.
10. Harrington WE, Mutabingwa TK, Kabyemela E, Fried M, Duffy PE, (2011) Intermittent treatment to prevent pregnancy malaria does not confer benefit in an area of widespread drug resistance. Clin Infec Dis 53: 224-230.
11. Nankabirwa J, Cundill B, Clarke S, Kabatereine N, Rosenthal PJ, et al. (2010) Efficacy, safety, and tolerability of three regimens for prevention of malaria: a randomized, placebo-controlled trial in Ugandan schoolchildren. PLoS ONE 5: e13438.
12. Snounou G, Viriyakosol S, Jarra W, Thaithong S, Brown KN, (1993) Identification of the four human malaria parasite species in field samples by the polymerase chain reaction and detection of a high prevalence of mixed infections. Mol Biochem Parasitol 58: 283-292.
13. Rogerson SJ, Pollina E, Getachew A, Tadesse E, Lema VM, et al. (2003) Placental monocyte infiltrates in response to Plasmodium falciparum malaria infection and their association with adverse pregnancy outcomes. Am J Trop Med Hyg 68: 115-119.
14. Vyas S, Kumaranayake L, (2006) Constructing socio-economic status indices: how to use principal components analysis. Health Policy Plan 21: 459-468.
15. ter Kuile FO, van Eijk AM, Filler SJ, (2007) Effect of sulfadoxine-pyrimethamine resistance on the efficacy of intermittent preventive therapy for malaria control during pregnancy: a systematic review. JAMA 297: 2603-2616.
16. Gesase S, Gosling RD, Hashim R, Ord R, Naidoo I, et al. (2009) High resistance of Plasmodium falciparum to sulphadoxine/pyrimethamine in northern Tanzania and the emergence of dhps resistance mutation at Codon 581. PLoS ONE 4: e4569.
17. Mutabingwa TK, Anthony D, Heller A, Hallett R, Ahmed J, et al. (2005) Amodiaquine alone, amodiaquine+sulfadoxine-pyrimethamine, amodiaquine+artesunate, and artemether-lumefantrine for outpatient treatment of malaria in Tanzanian children: a four-arm randomised effectiveness trial. Lancet 365: 1474-1480.
18. Feng G, Simpson JA, Chaluluka E, Molyneux ME, Rogerson SJ, (2010) Decreasing burden of malaria in pregnancy in Malawian women and its relationship to use of intermittent preventive therapy or bed nets. PLoS ONE 5: e12012.
19. Menendez C, Bardaji A, Sigauque B, Romagosa C, Sanz S, et al. (2008) A randomized placebo-controlled trial of intermittent preventive treatment in pregnant women in the context of insecticide treated nets delivered through the antenatal clinic. PLoS ONE 3: e1934.
20. Ndyomugyenyi R, Clarke SE, Hutchison CL, Hansen KS, Magnussen P, (2011) Efficacy of malaria prevention during pregnancy in an area of low and unstable transmission: an individually-randomised placebo-controlled trial using intermittent preventive treatment and insecticide-treated nets in the Kabale Highlands, southwestern Uganda. Trans Roy Soc Trop Med Hyg 105: 607-616.
21. World Health Organization. (2007) Technical Expert Group meeting on intermittent preventive treatment in pregnancy (IPTp). Geneva, Switzerland: WHO Headquarters.
22. Gregson A, Plowe CV, (2005) Mechanisms of resistance of malaria parasites to antifolates. Pharmacol Rev 57: 117-145.
23. Iriemenam NC, Shah M, Gatei W, van Eijk AM, Ayisi J, et al. (2012) Temporal trends of sulphadoxine-pyrimethamine (SP) drug-resistance molecular markers in Plasmodium falciparum parasites from pregnant women in western Kenya. Malaria J 11: 134.
24. Harrington WE, Mutabingwa TK, Muehlenbachs A, Sorensen B, Bolla MC, et al. (2009) Competitive facilitation of drug-resistant Plasmodium falciparum malaria parasites in pregnant women who receive preventive treatment. Proc Natl Acad Sci USA 106: 9027-9032.
25. Naidoo I, Roper C, (2011) Drug resistance maps to guide intermittent preventive treatment of malaria in African infants. Parasitology 138: 1469-1479.
26. Diakite OS, Kayentao K, Traore BT, Djimde A, Traore B, et al. (2011) Superiority of 3 over 2 doses of intermittent preventive treatment with sulfadoxine-pyrimethamine for the prevention of malaria during pregnancy in mali: a randomized controlled trial. Clin Infec Dis 53: 215-223.
27. Filler SJ, Kazembe P, Thigpen M, Macheso A, Parise ME, et al. (2006) Randomized trial of 2-dose versus monthly sulfadoxine-pyrimethamine intermittent preventive treatment for malaria in HIV-positive and HIV-negative pregnant women in Malawi. J Infec Dis 194: 286-293.
28. Hamer DH, Mwanakasale V, Macleod WB, Chalwe V, Mukwamataba D, et al. (2007) Two-dose versus monthly intermittent preventive treatment of malaria with sulfadoxine-pyrimethamine in HIV-seropositive pregnant Zambian women. J Infec Dis 196: 1585-1594.
29. Luntamo M, Rantala AM, Meshnick SR, Cheung YB, Kulmala T, et al. (2012) The effect of monthly sulfadoxine-pyrimethamine, alone or with azithromycin, on PCR-diagnosed malaria at delivery: a randomized controlled trial. PLoS ONE 7: e41123.
30. Kayentao K, Garner P, van Eijk AM, Naidoo I, Roper C, et al. (2013) Intermittent preventive therapy for malaria during pregnancy using 2 vs 3 or more doses of sulfadoxine-pyrimethamine and risk of low birth weight in Africa: systematic review and meta-analysis. JAMA 309: 594-604.